# Propofol EC50 for Inducing Loss of Consciousness in General Combined Epidural Anesthesia

> **NCT05124704** · NA · COMPLETED · sponsor: **Wang Jiangling** · enrollment: 60 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** 5-8ml 0.375% ropivacaine
- **OTHER:** 5-8ml normal saline

## Key facts

- **NCT ID:** NCT05124704
- **Lead sponsor:** Wang Jiangling
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-20
- **Primary completion:** 2022-05-25
- **Final completion:** 2022-05-25
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05124704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05124704, "Propofol EC50 for Inducing Loss of Consciousness in General Combined Epidural Anesthesia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05124704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*